United States · Business magazines · Quartz

Merck topped estimates and raised its profit forecast as cancer drug injection took off

Published by Quartz · United States 1 h ago

Adjusted profit forecast moves to $2.77 to $2.82 a share from $2.66 to $2.76 as Keytruda Qlex sales reach $830 million

Read the full article on Quartz Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)

Also worth reading

Halloween Reveals a Scary Mistake Even Smart Entrepreneurs Make

ECB’s president Christine Lagarde is resigning nine months early, giving EU leaders a chance to pick a successor before France’s elections

Your Adjustable-Rate Mortgage Is About to Reset. Here Are 5 Moves to Make Now

Purple is everywhere in fintech. This bank rebranded but kept the color

DoorDash strikes $17B deal for rival Instacart in bets on grocery delivery

D.C.'s foie gras ban could face a costly court fight